DURANTI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 12.971
EU - Europa 8.781
AS - Asia 5.108
SA - Sud America 429
AF - Africa 37
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 9
Totale 27.368
Nazione #
US - Stati Uniti d'America 12.824
CN - Cina 2.704
GB - Regno Unito 2.601
IT - Italia 1.836
UA - Ucraina 1.371
SG - Singapore 1.269
SE - Svezia 701
FI - Finlandia 516
TR - Turchia 492
RU - Federazione Russa 478
DE - Germania 451
BR - Brasile 338
IE - Irlanda 328
VN - Vietnam 220
FR - Francia 185
IN - India 123
CA - Canada 96
PL - Polonia 81
KR - Corea 57
NL - Olanda 54
JP - Giappone 53
ES - Italia 37
HK - Hong Kong 37
MX - Messico 33
AR - Argentina 32
BD - Bangladesh 29
AT - Austria 27
AU - Australia 27
BE - Belgio 26
ID - Indonesia 19
ZA - Sudafrica 17
CL - Cile 15
IQ - Iraq 13
IR - Iran 12
AE - Emirati Arabi Uniti 11
CH - Svizzera 10
PE - Perù 10
EC - Ecuador 9
LT - Lituania 9
SA - Arabia Saudita 9
CO - Colombia 8
HU - Ungheria 8
RO - Romania 8
UZ - Uzbekistan 8
EU - Europa 7
HR - Croazia 7
PK - Pakistan 7
PT - Portogallo 7
NZ - Nuova Zelanda 6
PY - Paraguay 6
IL - Israele 5
LV - Lettonia 5
SM - San Marino 5
TW - Taiwan 5
BG - Bulgaria 4
EG - Egitto 4
JM - Giamaica 4
JO - Giordania 4
KG - Kirghizistan 4
MY - Malesia 4
PH - Filippine 4
UY - Uruguay 4
VE - Venezuela 4
AM - Armenia 3
AZ - Azerbaigian 3
BY - Bielorussia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GR - Grecia 3
LU - Lussemburgo 3
MA - Marocco 3
NO - Norvegia 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
DK - Danimarca 2
EE - Estonia 2
HN - Honduras 2
KE - Kenya 2
LK - Sri Lanka 2
MD - Moldavia 2
NG - Nigeria 2
PA - Panama 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AL - Albania 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
CY - Cipro 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
IM - Isola di Man 1
IS - Islanda 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MT - Malta 1
Totale 27.360
Città #
Southend 2.316
Woodbridge 1.678
Ann Arbor 1.244
Houston 1.123
Jacksonville 1.090
Fairfield 1.052
Ashburn 904
Chandler 894
Nanjing 557
Singapore 555
Cambridge 476
Dallas 469
Wilmington 449
Seattle 434
Beijing 397
Izmir 345
Dublin 269
Boardman 256
Urbino 248
Helsinki 199
Nanchang 192
San Mateo 169
Princeton 161
New York 147
Hebei 118
Shenyang 118
Los Angeles 113
Changsha 98
Jiaxing 97
Istanbul 91
Tianjin 87
Velikiy Novgorod 82
Ho Chi Minh City 69
Düsseldorf 67
Santa Clara 60
Munich 59
Kunming 57
Council Bluffs 54
Milan 53
Buffalo 52
San Francisco 52
Seongnam 52
Menlo Park 48
Rome 48
San Diego 47
Dong Ket 46
Moscow 46
Toronto 46
Bremen 43
London 43
São Paulo 43
Shanghai 41
Hanoi 40
Nuremberg 38
Hong Kong 37
Guangzhou 34
Hangzhou 34
Warsaw 33
Jinan 32
Mülheim 32
Des Moines 31
Kraków 30
Changchun 28
Chicago 27
Stockholm 26
Brussels 24
Denver 24
Ningbo 23
Frankfurt am Main 22
Lanzhou 22
Mumbai 22
Montreal 20
Tokyo 20
Ancona 19
Brooklyn 19
Napoli 19
Palermo 19
Dearborn 18
Norwalk 18
Zhengzhou 18
Chennai 17
Haikou 17
Leawood 17
Taizhou 17
Amsterdam 16
Hefei 16
Manchester 16
Shenzhen 16
Cava De' Tirreni 15
Naples 15
Parma 15
Pesaro 15
Redwood City 15
Vienna 15
Ankara 14
Augusta 14
Mexico City 14
Rio de Janeiro 14
Bologna 13
Florence 13
Totale 18.487
Nome #
Inibitori dell’enzima NAAA (N-Acylethanolamine-Hydrolizing Acid Amidase) come nuovi agenti antinfiammatori 836
Unsaturated fatty acids lactose esters: cytotoxicity, permeability enhancement and antimicrobial activity 398
Pharmacokinetics, pharmacodynamics and safety studies on URB 937, a peripherally restricted fatty acid amide hydrolase inhibitor, in rats 359
Scoperta del primo inibitore dell’enzima idrolasi delle ammidi degli acidi grassi (FAAH) ad azione periferica 328
Derivatizzazione one-pot di indoli per la sintesi di triptofani, pirroloindoline, bis-indoli & co 325
2-Substituted-5-Methoxy-N-acyltryptamines: Synthesis, Binding Affinity for Melatonin Receptor, and Evaluation of the Biological Activity 270
A New Synthesis of 2-Substituted DL-Tryptophan Derivatives 270
Antidepressant-like Activity of the Fatty Acid Amide Hydrolase Inhibitor URB597 in a Rat Model of Chronic Mild Stress 266
A Second Generation of Carbamate-Based Fatty Acid Amide Hydrolase Inhibitors with Improved Activity in vivo 265
Structure–Property Relationships of a Class of Carbamate-Based Fatty Acid Amide Hydrolase (FAAH) Inhibitors: Chemical and Biological Stability 255
Antitumoral activity of indole-3-carbinol cyclic tri- and tetrameric derivatives mixture in human breast cancer cells: in vitro and in vivo studies 254
Sintesi e studi di relazione struttura-attività/stabilità di carbammati inibitori dell’enzima FAAH 252
The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin1A and serotonin2A/C activity in the hippocampus 242
Synthesis, Structure-Activity Relationships and In Vitro Toxicity Profile of Lactose-Based Fatty Acid Monoesters as Possible Drug Permeability Enhancers 242
Biphenyl-3-yl alkylcarbamates as fatty acid amide hydrolase (FAAH) inhibitors: Steric effects of N-alkyl chain on rat plasma and liver stability 240
The Synthetic Cannabinoid URB447 Reduces Brain Injury and the Associated White Matter Demyelination After Hypoxia-Ischemia in Neonatal Rats 238
Identification of a Bioactive Impurity in a Commercial Sample of 6-Methyl-2-p-tolylaminobenzo[d][1,3]oxazin-4-one (URB754) 235
Lactose oleate as new biocompatible surfactant for pharmaceutical applications 235
2-Bromomelatonin: Synthesis and characterization of a potent melatonin agonist 229
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis 228
Synthesis and Biological Evaluation of a γ-Cyclodextrin-based Formulation of the Anticancer Agent 5,6,11,12,17,18,23,24-Octahydrocyclododeca[1,2-b:4,5-b’:7,8-b’’:10,11-b’’’]tetraindole (CTet) 228
Induction of Endoplasmic Reticulum Stress Response by the Indole-3-Carbinol Cyclic Tetrameric Derivative CTet in Human Breast Cancer Cell Lines 228
Modulation of Anxiety Through Blockade of Anandamide Hydrolysis 221
Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation 221
Synthesis and Evaluation of Saccharide-Based Aliphatic and Aromatic Esters as Antimicrobial and Antibiofilm Agents 221
Pretreatment with the monoacylglycerol lipase inhibitor URB602 protects from the long-term consequences of neonatal hypoxic-ischemic brain injury in rats 216
Cyclohexylcarbamic Acid 3’-or 4’-Substituted Biphenyl-3-yl Esters as Fatty Acid Amide Hydrolase Inhibitors: Synthesis Quantitative Structure–Activity Relationships, and Molecular Modeling Studies 216
Composition and Methods of Inhibiting N-Acylethanolamine-hydrolyzing Acid Amidase 214
A practical and expeditious method for the preparation of the anticancer agent 5,6,11,12,17,18,23,24-octahydrocyclododeca[1,2-b:4,5-b’:7,8-b’’:10,11-b’’’]tetraindole (CTet) 208
A combination of sugar esters and chitosan to promote in vivo wound care 207
An endocannabinoid mechanism for stress-induced analgesia 206
Mechanisms of action and antiproliferative properties of URB631 in human breast cancer 205
The indole-3-carbinol tetrameric derivative CTet inhibits cell proliferation via overexpression of p21/CDKN1A in both estrogen receptor-positive and triple-negative breast cancer cell lines 205
Synthesis and Structure–Activity Relationships of a Series of Pyrrole Cannabinoid Receptor Agonists 204
Anandamide suppressess pain initiation through a peripheral endocannabinoid mechanism 204
Synthesis and Structure–Activity Relationship (SAR) of 2-Methyl-4-oxo-3-oxetanyl Carbamic Acid Esters, a Class of Potent N-Acylethanolamine Acid Amidase (NAAA) Inhibitors 199
O-Biphenyl-3-yl Carbamates as Peripheral FAAH Inhibitors: Synthesis and Structure–Activity (SAR) Relationship Studies 198
Indole-3-carbinol (I3C) Tetrameric Derivative (CTet) Inhibits Cell Cycle Progression Inducing Overexpression of p21/cip1/waf1 and GADD45A in Breast Cancer Cell Lines 198
Peripherally Restricted FAAH Inhibitors 197
Endocannabinoids in the Treatment of Mood Disorders: Evidence from Animal Models 194
Synthesis and Quantitative Structure–Activity Relationship of Fatty Acid Amide Hydrolase Inhibitors: Modulation at the N-Portion of Biphenyl-3-yl Alkylcarbamates 193
2-Substituted-5-Methoxy-N-acyltryptamines: Synthesis and Binding Affinity to the Melatonin Receptor 191
Structural determinants of peripheral O-arylcarbamate FAAH inhibitors render them dual substrates for Abcb1 and Abcg2 and restrict their access to the brain 191
Design, Synthesis and Structure–Activity Relationships of Alkylcarbamic Acid Aryl Esters, a New Class of Fatty Acid Amide Hydrolase Inhibitors 189
The Fatty Acid Amide Hydrolase Inhibitor URB597 (Cyclohexylcarbamic Acid 3’-Carbamoylbiphenyl-3-yl Ester) Reduces Neuropathic Pain after Oral Administration in Mice 186
Antimyotonic effects of enantiomers of mexiletine-like drugs 185
Sintesi e studi biologici preliminari su analoghi di URB937, il primo inibitore ad azione periferica dell'enzima FAAH 185
Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat 184
Therapeutic Effects of Tocainide and Mexiletine Analogs on Myotonic MTO and ADR Mice 183
Application of 3D-QSAR in the Rational Design of Receptor Ligands and Enzyme Inhibitors 183
2 - Arachidonoylglycerol and anandamide are endocannabinoid mediators of stress - induced analgesia 182
A Versatile Biomimetic Approach to Diindolylmethane Derivatives as Potential Anticancer Agents 182
URB602 Inhibits Monoacylglycerol Lipase and Selectively Blocks 2-Arachidonoylglycerol Degradation in Intact Brain Slices 181
Modulation of anxiety through blockade of anandamide hydrolysis 181
Synthesis and Structure–Activity Relationships of FAAH Inhibitors: Cyclohexylcarbamic Acid Biphenyl Esters with Chemical Modulation at the Proximal Phenyl Ring 180
Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus 178
Endocannabinoid Regulation of Acute and Protracted Nicotine Withdrawal: Effect of FAAH Inhibition 178
Derivato tetramerico ciclico dell’indol-3-carbinolo CTet come chemiopreventivo in tumori al seno estrogeno-dipendenti 175
N-(2-Oxo-3-oxetanyl)carbamic Acid Esters as N-Acylethanolamine Acid Amidase Inhibitors: Synthesis, Structure–Activity and Structure–Property Relationships 175
Synthesis and characterization of a peripherally restricted CB1 cannabinoid antagonist, URB447, that reduces feeding and body-weight gain in mice 174
Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat 174
The collisional behavior of ESI-generated protonated molecules of some carbamate FAAH inhibitors isosteres and its relationships with biological activity 174
Synthesis and Structure–Activity Relationship Studies of O-Biphenyl-3-yl Carbamates as Peripherally Restricted Fatty Acid Amide Hydrolase Inhibitors 173
SYNTHESIS AND EVALUATION OF SUGAR-BASED ALIPHATIC AND AROMATIC FATTY ACID ESTERS AS ANTIMICROBIAL AND ANTIBIOFILM AGENTS 173
Synthesis and Structure–Activity Relationships of N-(2-Oxo-3-oxetanyl)amides as N-Acylethanolamine-hydrolyzing Acid Amidase Inhibitors 172
The fatty-acid amide hydrolase inhibitor URB597 does not affect triacylglycerol hydrolysis in rat tissues 170
Pharmacological Profile of the Selective FAAH Inhibitor KDS-4103 (URB597) 169
α-Acylamino-β-lactones as a new class of N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitors: synthesis and structure–activity relationships 168
N-alchil-O-arilcarbammati come inibitori delle idrolasi delle ammidi degli acidi grassi (FAAH): aspetti meccanicistici 168
Homologation of mexiletine alkyl chain and stereoselective blockade of skeletal muscle sodium channels 167
Design, synthesis, and pharmacological effects of structurally simple ligands for MT1 and MT2 melatonin receptors 166
Synthesis and Structure-Activity/Stability Relationships of Carbamate Inhibitors of the FAAH Enzyme 165
Selective inhibition of 2 - AG hydrolysis enhances endocannabinoid signaling in the hippocampus 164
The CB1 Antagonist/CB2 Agonist URB447 Confers Neuroprotection after Neonatal Hypoxia-ischemia 163
Identification of a Bioactive Impurity Present in a Sample of URB754 158
A linear relationship between MS/MS data and FAAH inhibitory activity of some carbamates 158
Sintesi e studi di relazione struttura–attività/selettività su O-bifenil-3-ilcarbammati disostituiti quali inibitori periferici dell’enzima FAAH 154
Stereospecific synthesis of mexiletine and related compounds: Mitsunobu versus Williamson reaction 150
Contribution to the Study of 2-Aryloxy-1-phenyl and 2-Aryloxy-2-phenylethanols. Differentiation by Mass Spectrometry 150
3D-QSAR study of carbamic acid aryl ester inhibitors of fatty acid amide hydrolase 148
Characterization of the Fatty Acid Amide Hydrolase Inhibitor Cyclohexyl Carbamic Acid 3'-Carbamoyl-biphenyl-3-yl Ester (URB597): Effects on Anandamide and Oleoylethanolamide Deactivation 147
Design, SAR and Biological Activity of a New Class of FAAH Inhibitors: Cyclohexyl Carbamic Acid Biphenyl-3-yl Esters 147
Synthesis and pharmacological characterization of URB447, a new cannabinoid receptor neutral antagonist 145
Anestetici locali (Cap. 14) 145
2,6-Xilididi e β-2,6-xililossietilammine come ligandi anfipatici per i recettori benzodiazepinici di tipo mitocondriale 144
Analoghi chirali della mexiletina: attività sui canali ionici 144
Antinociceptive effects of the brain-impermeant fatty-acid amide hydrolase inhibitor URB937 143
Tandem mass spectrometric data–FAAH inhibitors activity relationships of some carbamic acid O-aryl esters 140
Relationships Between Mass Spectrometry and Biological Stability of Some N-Acylethanolamine Acid Amidase Inhibitors 138
Chronic stimulation of the endogenous anandamide tone reduces cocaine-seeking and cue-induced relapse in rats 137
URB602, a Monoacylglycerol Lipase Inhibitor, Protects from the Long-term Consequences of a Neonatal Hypoxic-ischemic Brain Injury in Rats 135
Inhibitors of lysosomal lipid amidase NAAA 135
QSAR and molecular modelling investigations of a new series of alkyl carbamic acid aryl ester inhibitors of fatty acid amide hydrolase 134
Antinoceptive Effects of the N-Acylethanolamine Acid Amidase Inhibitor ARN077 in Rodent Pain Models 134
FAAH and MGL Inhibitors. Design and Therapeutic Implications 133
Composition and Methods of Inhibiting N-Acylethanolamine-hydrolyzing Acid Amidase 132
Structure-Activity Relationships of Alkylcarbamic Acid Aryl Esters, as Fatty Acid Amide Hydrolase Inhibitors 130
Cannabinoids Modify Hippocampal Serotonergic Transmission 129
Synthesis and Antiplatelet Activity of Gemfibrozil Chiral Analogues 129
Synthesis and Pharmacological Characterization of Potent and Selective Inhibitors of Fatty Acid Amidohydrolase (FAAH) 128
Totale 19.846
Categoria #
all - tutte 98.969
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.969


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.794 0 0 0 0 0 210 149 199 371 320 386 159
2021/20221.758 89 219 205 183 71 41 83 97 121 99 47 503
2022/20232.761 312 129 65 357 215 574 42 241 467 93 149 117
2023/2024781 96 54 56 91 54 166 37 49 15 66 28 69
2024/20252.662 139 140 619 204 97 192 296 152 244 160 237 182
2025/20263.653 538 724 779 1.069 508 35 0 0 0 0 0 0
Totale 27.633